Bioengineering methods for myocardial regeneration

Advanced Drug Delivery Reviews

Volumn 96, Issue , 2016, Pages 195-202

  Parsa, Hesam ^a   Ronaldson, Kacey ^a   Vunjak Novakovic, Gordana ^a,b  

^a Department of Earth and Environmental Sciences   (United States)

^b NONE   (United States)

Author keywords

Bioreactor; Cardiomyocyte; Cell and tissue delivery to the heart; Electro mechanical stimulation; Human induced pluripotent stem cells; Tissue engineering

Indexed keywords

BIOREACTORS; CELL ENGINEERING; CELLS; CYTOLOGY; HEART; HISTOLOGY; SCAFFOLDS (BIOLOGY); STEM CELLS; TISSUE; TISSUE ENGINEERING;

BIOENGINEERING METHODS; BIOREACTOR SYSTEM; CARDIOMYOCYTES; ELECTRO-MECHANICAL; ENGINEERED TISSUES; ENGINEERING METHODS; HEART DEVELOPMENT; HUMAN-INDUCED PLURIPOTENT STEM CELLS;

TISSUE REGENERATION;

BIOENGINEERING; BIOREACTOR; CALCIUM SIGNALING; ELECTROSTIMULATION; EXCITATION CONTRACTION COUPLING; EXTRACELLULAR MATRIX; HEART DEVELOPMENT; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CONTRACTILE FORCE; HUMAN; INFLAMMATION; INTRACARDIAC PATCH; MECHANICAL STIMULATION; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE SCAFFOLD; VASCULARIZATION; ANIMAL; BIOMECHANICS; BIOPHYSICS; CARDIAC MUSCLE CELL; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; ELECTROPHYSIOLOGY; HEART; INDUCED PLURIPOTENT STEM CELL; PHYSIOLOGY; PROCEDURES; REGENERATION;

ANIMALS; BIOMECHANICAL PHENOMENA; BIOPHYSICAL PHENOMENA; BIOREACTORS; CELL DIFFERENTIATION; ELECTROPHYSIOLOGICAL PHENOMENA; HEART; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCYTES, CARDIAC; REGENERATION; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84951772293     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2015.06.012     Document Type: Review

References (78)

1. Roger V.L., et al. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 2012, 125(1):e2-e220.
2. Minino A.M. Death in the United States, 2011. NCHS Data Brief 2013, (115):1-8.
3. Pedron S., et al. Stimuli responsive delivery vehicles for cardiac microtissue transplantation. Adv. Funct. Mater. 2011, 21(9):1624-1630.
4. Wang F., Guan J.J. Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy. Adv. Drug Deliv. Rev. 2010, 62(7-8):784-797.
5. Chavakis E., Koyanagi M., Dimmeler S. Enhancing the outcome of cell therapy for cardiac repair progress from bench to bedside and back. Circulation 2010, 121(2):325-335.
6. Liu J.B., et al. Autologous stem cell transplantation for myocardial repair. Am. J. Physiol. Heart Circ. Physiol. 2004, 287(2):H501-H511.
7. Prabhakaran M.P., et al. Biomimetic material strategies for cardiac tissue engineering. Mater. Sci. & Eng. C Mater. Biol. Appl. 2011, 31(3):503-513.
8. Nunes S.S., et al. Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat. Methods 2013, 10(8):781-787.
9. Chong J.J., et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 2014, 510(7504):273-277.
10. Mitcheson J.S., Hancox J.C., Levi A.J. Cultured adult cardiac myocytes: future applications, culture methods, morphological and electrophysiological properties. Cardiovasc. Res. 1998, 39(2):280-300.
11. Marelli D., et al. Cell transplantation for myocardial repair: an experimental approach. Cell Transplant. 1992, 1(6):383-390.
12. Moscona A.A. Tissues from dissociated cells. Sci. Am. 1959, 200(5):132-134. (passim).
13. Parker K.K., et al. Myofibrillar architecture in engineered cardiac myocytes. Circ. Res. 2008, 103(4):340-342.
14. Vandenburgh H.H., Karlisch P., Farr L. Maintenance of highly contractile tissue-cultured avian skeletal myotubes in collagen gel. In Vitro Cell. Dev. Biol. 1988, 24(3):166-174.
15. Eschenhagen T., et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J. 1997, 11(8):683-694.
16. Radisic M., et al. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(52):18129-18134.
17. Chicurel M.E., et al. Integrin binding and mechanical tension induce movement of mRNA and ribosomes to focal adhesions. Nature 1998, 392(6677):730-733.
18. Hammond G.L., Wieben E., Markert C.L. Molecular Signals for Initiating Protein-Synthesis in Organ Hypertrophy. Proc. Natl. Acad. Sci. U. S. A. 1979, 76(5):2455-2459.
19. Matsuda T., et al. N-cadherin-mediated cell adhesion determines the plasticity for cell alignment in response to mechanical stretch in cultured cardiomyocytes. Biochem. Biophys. Res. Commun. 2005, 326(1):228-232.
20. Yamane M., et al. Rac 1 activity is required for cardiac myocyte alignment in response to mechanical stress. J. Pharmacol. Sci. 2007, 103:98p-98p.
21. Gupta V., Grande-Allen K.J. Effects of static and cyclic loading in regulating extracellular matrix synthesis by cardiovascular cells. Cardiovasc. Res. 2006, 72(3):375-383.
22. Opie L.H., et al. Controversies in ventricular remodelling. Lancet 2006, 367(9507):356-367.
23. Lindsey S.E., Butcher J.T., Yalcin H.C. Mechanical regulation of cardiac development. Front. Physiol. 2014, 5:318.
24. Cirotto C., Arangi I. How do avian embryos breathe - oxygen-transport in the blood of early chick-embryos. Comp. Biochem. Physiol. A Physiol. 1989, 94(4):607-613.
25. Granados-Riveron J.T., Brook J.D. The impact of mechanical forces in heart morphogenesis. Circ. Cardiovasc. Genet. 2012, 5(1):132-142.
26. Nuccitelli R. Endogenous ionic currents and DC electric fields in multicellular animal tissues. Bioelectromagnetics 1992, (Suppl. 1):147-157.
27. Ypey D.L., Clapham D.E., DeHaan R.L. Development of electrical coupling and action potential synchrony between paired aggregates of embryonic heart cells. J. Membr. Biol. 1979, 51(1):75-96.
28. Levin M. Motor protein control of ion flux is an early step in embryonic left-right asymmetry. Bioessays 2003, 25(10):1002-1010.
29. Bartman T., et al. Early myocardial function affects endocardial cushion development in zebrafish. PLoS Biol. 2004, 2(5):E129.
30. Berdougo E., et al. Mutation of weak atrium/atrial myosin heavy chain disrupts atrial function and influences ventricular morphogenesis in zebrafish. Development 2003, 130(24):6121-6129.
31. Chi N.C., et al. Cardiac conduction is required to preserve cardiac chamber morphology. Proc. Natl. Acad. Sci. U. S. A. 2010, 107(33):14662-14667.
32. Srivastava D., Olson E.N. A genetic blueprint for cardiac development. Nature 2000, 407(6801):221-226.
33. Hove J.R., et al. Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature 2003, 421(6919):172-177.
34. Godier-Furnemont A.F., et al. Composite scaffold provides a cell delivery platform for cardiovascular repair. Proc. Natl. Acad. Sci. U. S. A. 2011, 108(19):7974-7979.
35. Duan Y., et al. Hybrid gel composed of native heart matrix and collagen induces cardiac differentiation of human embryonic stem cells without supplemental growth factors. J. Cardiovasc. Transl. Res. 2011, 4(5):605-615.
36. Nonaka S., et al. Randomization of left-right asymmetry due to loss of nodal cilia generating leftward flow of extraembryonic fluid in mice lacking KIF3B motor protein. Cell 1998, 95(6):829-837.
37. Sekine H., et al. In vitro fabrication of functional three-dimensional tissues with perfusable blood vessels. Nat. Commun. 2013, 4:1399.
38. Radisic M., et al. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng. 2006, 12(8):2077-2091.
39. Tandon N., et al. Portable bioreactor for perfusion and electrical stimulation of engineered cardiac tissue. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2013, 2013:6219-6223.
40. Maidhof R., et al. Biomimetic perfusion and electrical stimulation applied in concert improved the assembly of engineered cardiac tissue. J. Tissue Eng. Regen. Med. 2012, 6(10):e12-e23.
41. Zimmermann W.H., et al. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol. Bioeng. 2000, 68(1):106-114.
42. Zimmermann W.H., et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 2006, 12(4):452-458.
43. Robey T.E., et al. Systems approaches to preventing transplanted cell death in cardiac repair. J. Mol. Cell. Cardiol. 2008, 45(4):567-581.
44. Zvibel I., Smets F., Soriano H. Anoikis: roadblock to cell transplantation?. Cell Transplant. 2002, 11(7):621-630.
45. Jennings R.B., Reimer K.A., Steenbergen C. Myocardial ischemia revisited. The osmolar load, membrane damage, and reperfusion. J. Mol. Cell. Cardiol. 1986, 18(8):769-780.
46. Kalogeris T., Bao Y., Korthuis R.J. Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning. Redox Biol. 2014, 2:702-714.
47. Nahrendorf M., et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 2007, 204(12):3037-3047.
48. Dow J., et al. Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. Cardiovasc. Res. 2005, 67(2):301-307.
49. Qiao H., et al. Death and proliferation time course of stem cells transplanted in the myocardium. Mol. Imaging Biol. 2009, 11(6):408-414.
50. Zhang M., et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell. Cardiol. 2001, 33(5):907-921.
51. Hofmann M., et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005, 111(17):2198-2202.
52. Cao F., et al. Spatial and temporal kinetics of teratoma formation from murine embryonic stem cell transplantation. Stem Cells Dev. 2007, 16(6):883-891.
53. Roche E.T., et al. Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart. Biomaterials 2014, 35(25):6850-6858.
54. Dib N., et al. Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research. JACC Cardiovasc. Interv. 2010, 3(3):265-275.
55. Sherman W., et al. Catheter-based delivery of cells to the heart. Nat. Clin. Pract. Cardiovasc. Med. 2006, 3(Suppl. 1):S57-S64.
56. Kochupura P.V., et al. Tissue-engineered myocardial patch derived from extracellular matrix provides regional mechanical function. Circulation 2005, 112(9 Suppl):I144-I149.
57. Wei H.J., et al. Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair. Biomaterials 2008, 29(26):3547-3556.
58. Wendel J.S., et al. Functional Consequences of a Tissue-Engineered Myocardial Patch for Cardiac Repair in a Rat Infarct Model. Tissue Eng. A 2014, 20(7-8):1325-1335.
59. Dib N., et al. Cell therapy for cardiovascular disease: a comparison of methods of delivery. J. Cardiovasc. Transl. Res. 2011, 4(2):177-181.
60. Hou D., et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 2005, 112(9 Suppl):I150-I156.
61. Strauer B.E., Kornowski R. Stem cell therapy in perspective. Circulation 2003, 107(7):929-934.
62. Sarig U., Machluf M. Engineering cell platforms for myocardial regeneration. Expert. Opin. Biol. Ther. 2011, 11(8):1055-1077.
63. Sakaguchi K., et al. In vitro engineering of vascularized tissue surrogates. Sci. Rep. 2013, 3:1316.
64. Shiba Y., et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 2012, 489(7415):322-325.
65. Dubose T.J., Cunyus J.A., Johnson L.F. Embryonic Heart-Rate and Age. J. Diagn. Med. Sonography 1990, 6(3):151-157.
66. Mihic A., et al. The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes. Biomaterials 2014, 35(9):2798-2808.
67. Kowalski W.J., et al. Investigating developmental cardiovascular biomechanics and the origins of congenital heart defects. Front. Physiol. 2014, 5:408.
68. Ye L., et al. Patching the Heart Cardiac Repair From Within and Outside. Circ. Res. 2013, 113(7):922-932.
69. Montgomery M., Zhang B., Radisic M. Cardiac tissue vascularization: from angiogenesis to microfluidic blood vessels. J. Cardiovasc. Pharmacol. Ther. 2014, 19(4):382-393.
70. Caspi O., et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 2007, 100(2):263-272.
71. Narmoneva D.A., et al. Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation 2004, 110(8):962-968.
72. Rakusan K., et al. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy. Circulation 1992, 86(1):38-46.
73. Mantovani A., et al. Macrophage plasticity and polarization in tissue repair and remodelling. J. Pathol. 2013, 229(2):176-185.
74. Spiller K.L., Freytes D.O., Vunjak-Novakovic G. Macrophages modulate engineered human tissues for enhanced vascularization and healing. Ann. Biomed. Eng. 2015, 43(3):616-627.
75. Laflamme M.A., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 2007, 25(9):1015-1024.
76. Legant W.R., et al. Microfabricated tissue gauges to measure and manipulate forces from 3D microtissues. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(25):10097-10102.
77. Wang G., et al. Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies. Nat. Med. 2014, 20(6):616-623.
78. Meyer U. Fundamentals of tissue engineering and regenerative medicine 2009, Springer, Berlin, (xxvi, 1049 pp.).